- IN₹9.71bn
- IN₹10.87bn
- IN₹6.15bn
- 63
- 43
- 26
- 40
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.85 | ||
| Price to Tang. Book | 1.94 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.43 | ||
| EV to EBITDA | 13.91 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.11% | ||
| Return on Equity | 10.12% | ||
| Operating Margin | 9.19% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,594.99 | 4,918.14 | 4,775.21 | 5,509.87 | 6,145.92 | n/a | n/a | 11.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -10.64 | +186.88 | -3.44 | -58.99 | +87.11 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, EDS, anti-diabetic, CNS, pain management, gastroenterology, and respiratory. It manufactures a range of APIs, including Sterile Cephalosporins and Carbapenems. It has a portfolio, producing over 100 dosage forms that meet international quality standards. These include tablets, capsules, dry powder, suspension and injectables.
Directors
- Surendra Somani VCH (57)
- Ajit Jain COO (50)
- Sunil Sodhani CCO
- Susheel Somani DRC
- Adarsh Somani NED (44)
- Varun Somani NED (35)
- Sunita Banerji IND
- V. Bhandari IND
- Siddhan Subramanian IND
- A. Mehta NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 26th, 1958
- Public Since
- November 17th, 1992
- No. of Shareholders
- 51,705
- No. of Employees
- 358
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India- Shares in Issue
- 48,285,605
- Address
- Parijat House, MUMBAI, 400018
- Web
- https://www.kopran.com/
- Phone
- +91 2243661111
- Contact
- Chandni Shah
- Auditors
- Khandelwal Jain & Co.
Upcoming Events for KOPRAN
Q1 2026 Kopran Ltd Earnings Release
Kopran Ltd Annual Shareholders Meeting
Similar to KOPRAN
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Kopran share price?
As of Today at 21:38 UTC, shares in Kopran are trading at IN₹190.58. This share price information is delayed by 15 minutes.
How has the Kopran share price performed this year?
Shares in Kopran last closed at IN₹190.58 and the price had moved by -26.56% over the past 365 days. In terms of relative price strength the Kopran share price has underperformed the S&P BSE 100 Index by -30.82% over the past year.
What are the analyst and broker recommendations for Kopran?
The overall consensus recommendation for Kopran is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kopran dividend yield?
The Kopran dividend yield is 1.57% based on the trailing twelve month period.
Does Kopran pay a dividend?
Last year, Kopran paid a total dividend of IN₹3.00, and it currently has a trailing dividend yield of 1.57%. We do not have any data on when Kopran is to next pay dividends.
When does Kopran next pay dividends?
We do not have data on when Kopran is to next pay dividends. The historic dividend yield on Kopran shares is currently 1.57%.
How do I buy Kopran shares?
To buy shares in Kopran you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kopran?
As of the previous close price of IN₹190.58, shares in Kopran had a market capitalisation of IN₹9.71bn.
Where are Kopran shares listed?
Here are the trading details for Kopran:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: KOPRAN
What kind of share is Kopran?
Based on an overall assessment of its quality, value and momentum Kopran is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kopran share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Kopran share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kopran. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -31.41%.
As of the last closing price of IN₹190.58, shares in Kopran were trading -20.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kopran PE Ratio?
The Kopran PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹190.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kopran?
Kopran's management team is headed by:
- Surendra Somani - VCH
- Ajit Jain - COO
- Sunil Sodhani - CCO
- Susheel Somani - DRC
- Adarsh Somani - NED
- Varun Somani - NED
- Sunita Banerji - IND
- V. Bhandari - IND
- Siddhan Subramanian - IND
- A. Mehta - NID